论文信息 - Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived Malignancy. - 字舞流文

Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived Malignancy.

R. Varadhan | Richard J. Jones | L. Swinnen | Y. Kasamon | P. Brown | R. Ambinder | L. Luznik | E. Fuchs | R. Majzner | K. Cooke | H. Symons | J. Kanakry | J. Bolaños-Meade | Huzefa J. Mogri